Published in J Clin Microbiol on February 01, 1986
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol (1999) 11.94
Comparison of Directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus. J Clin Microbiol (1991) 2.66
Rapid detection of influenza virus by shell vial assay with monoclonal antibodies. J Clin Microbiol (1986) 2.31
Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J Virol (2007) 2.23
Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol (1988) 2.22
A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response. J Infect Dis (2014) 2.04
Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay. J Clin Microbiol (1995) 1.80
Rapid diagnosis of influenza A and B by 24-h fluorescent focus assays. J Clin Microbiol (1988) 1.57
Time-resolved fluoroimmunoassay with monoclonal antibodies for rapid diagnosis of influenza infections. J Clin Microbiol (1986) 1.56
Detection of influenza virus by centrifugal inoculation of MDCK cells and staining with monoclonal antibodies. J Clin Microbiol (1989) 1.33
Direct detection of influenza virus antigen in nasopharyngeal specimens by direct enzyme immunoassay in comparison with quantitating virus shedding. J Clin Microbiol (1992) 1.33
Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies. J Clin Microbiol (1990) 1.29
Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J Virol (2012) 1.20
Application of subtype-specific monoclonal antibodies for rapid detection and identification of influenza A and B viruses. J Clin Microbiol (1998) 1.13
Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. Vaccine (2012) 1.09
Evaluation of monoclonal antibodies for subtyping of currently circulating human type A influenza viruses. J Clin Microbiol (1997) 1.00
Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and directed to clade 1 strains. Clin Vaccine Immunol (2008) 0.95
A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development. J Virol (2009) 0.94
Enhancing effect of centrifugation on isolation of influenza virus from clinical specimens. J Clin Microbiol (1990) 0.92
Rapid Tests for Influenza. Curr Infect Dis Rep (2005) 0.89
Rapid method for detection of influenza a and B virus antigens by use of a two-photon excitation assay technique and dry-chemistry reagents. J Clin Microbiol (2007) 0.89
Influenza virus- and cytokine-immunoreactive cells in the murine olfactory and central autonomic nervous systems before and after illness onset. J Neuroimmunol (2009) 0.88
Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins. J Clin Microbiol (2002) 0.85
A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment. Virol J (2013) 0.83
Early detection of influenza virus by using a fluorometric assay of infected tissue culture. J Clin Microbiol (1988) 0.82
Economical laboratory support system for influenza virus surveillance. J Clin Microbiol (1987) 0.82
Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production. BMC Biotechnol (2008) 0.80
Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children. Pediatr Infect Dis J (2014) 0.75
COBRA HA elicits hemagglutination-inhibition antibodies against a panel of H3N2 influenza virus co-circulating variants. J Virol (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol (1976) 30.70
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol (1983) 6.86
India ink staining of proteins on nitrocellulose paper. Anal Biochem (1983) 5.78
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
Detection of influenza A virus by radioimmunoassay and enzyme-immunoassay from nasopharyngeal specimens. J Med Virol (1981) 2.47
New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet (1980) 2.35
Monoclonal antibodies for the rapid diagnosis of influenza A and B virus infections by immunofluorescence. Lancet (1985) 2.30
Antigenic variation of influenza A virus nucleoprotein detected with monoclonal antibodies. J Virol (1980) 2.00
Monoclonal antibodies for rapid, strain-specific identification of influenza virus isolates. J Clin Microbiol (1982) 1.89
Analysis of antigenic drift in the haemagglutinin molecule of influenza B virus with monoclonal antibodies. J Gen Virol (1981) 1.85
Antigenic characterization of influenza A virus matrix protein with monoclonal antibodies. J Virol (1984) 1.49
Heterogeneity of influenza B viruses. Bull World Health Organ (1983) 1.39
Detection of viral antigens by time-resolved fluoroimmunoassay. Curr Top Microbiol Immunol (1983) 1.33
Evaluation of a solid-phase immunoassay with fluorescein isothiocyanate-conjugated heterogeneous or monoclonal antibodies for identification of virus isolates, with influenza virus as a model. J Clin Microbiol (1982) 1.11
Detection of monoclonal influenza antibodies synthesized in culture by hybridoma cells with a solid-phase indirect immunofluorometric assay. J Virol Methods (1980) 1.09
An outbreak of influenza aboard a commercial airliner. Am J Epidemiol (1979) 5.51
Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health (1987) 4.87
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology (1990) 4.71
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol (1983) 3.70
Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med (1988) 3.49
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology (1986) 3.34
Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology (1977) 2.90
Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology (1988) 2.62
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61
The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics (2001) 2.55
Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. Virology (1979) 2.45
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun (1980) 2.42
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res (1983) 2.41
Rapid detection of influenza virus by shell vial assay with monoclonal antibodies. J Clin Microbiol (1986) 2.31
Monoclonal antibodies for the rapid diagnosis of influenza A and B virus infections by immunofluorescence. Lancet (1985) 2.30
Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol (1988) 2.22
Effect of neuraminidase antibody on Hong Kong influenza. Lancet (1973) 2.11
Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza. J Clin Microbiol (1989) 2.09
Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93
Recombination of human influenza A viruses in nature. Nature (1980) 1.92
Laboratory-based surveillance of influenza A(H1N1) and A(H3N2) viruses in 1980-81: antigenic and genomic analyses. Bull World Health Organ (1983) 1.89
Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis (1977) 1.88
Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain. Arch Virol (1977) 1.81
Enzyme immunoassay for direct detection of influenza type A and adenovirus antigens in clinical specimens. J Clin Microbiol (1982) 1.71
Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis (1993) 1.69
Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. J Gen Virol (1992) 1.69
Studies with avian influenza A viruses: cross protection experiments in chickens. J Gen Virol (1971) 1.66
A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides. Virology (1975) 1.63
Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol (1991) 1.62
Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986-1991. Virus Res (1993) 1.59
The next influenza pandemic: lessons from Hong Kong, 1997. Emerg Infect Dis (1999) 1.58
Age-related heterologous antibody responses to influenza virus vaccination. J Infect Dis (1977) 1.57
Time-resolved fluoroimmunoassay with monoclonal antibodies for rapid diagnosis of influenza infections. J Clin Microbiol (1986) 1.56
Antigenic and genomic analyses of influenza A(H1N1) viruses from different regions of the world, February 1978 to March 1980. Infect Immun (1981) 1.55
Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Infect Immun (1979) 1.51
Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol (1991) 1.47
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Identification of the binding sites to monoclonal antibodies on A/USSR/90/77 (H1N1) hemagglutinin and their involvement in antigenic drift in H1N1 influenza viruses. Virology (1983) 1.45
Pathways of evolution of influenza A (H1N1) viruses from 1977 to 1986 as determined by oligonucleotide mapping and sequencing studies. J Gen Virol (1989) 1.43
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother (1984) 1.42
An outbreak of influenza A/Taiwan/1/86 (H1N1) infections at a naval base and its association with airplane travel. Am J Epidemiol (1989) 1.39
Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. J Infect Dis (1977) 1.39
Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. J Clin Microbiol (1983) 1.39
Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species. Arch Virol (1995) 1.38
Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. J Infect Dis (1984) 1.37
Laboratory-based surveillance of influenza virus in the United States during the winter of 1977--1978. II. Isolation of a mixture of A/Victoria- and A/USSR-like viruses from a single person during an epidemic in Wyoming, USA, January 1978. Am J Epidemiol (1979) 1.37
Further studies of the antigenic properties of H3N2 strains of influenza A isolated from swine in South East Asia. J Gen Virol (1979) 1.35
Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics (2001) 1.33
Influenza neuraminidase antibody patterns of man. Am J Epidemiol (1973) 1.32
Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis (1982) 1.31
Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol (1993) 1.31
Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers. Infect Immun (1978) 1.30
Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers. Infect Immun (1981) 1.27
A cluster of meningococcal disease on a school bus following epidemic influenza. Arch Intern Med (1991) 1.23
Swine-like influenza virus infection in a Wisconsin farm family. J Infect Dis (1977) 1.20
A comparative study of influenza virus neuraminidases, using automated techniques. Biochim Biophys Acta (1969) 1.16
An imporved procedure for measuring neuraminidase antibodies by hemagglutination-inhibition. Z Naturforsch B (1972) 1.15
Use of influenza vaccine in nursing homes. J Am Geriatr Soc (1985) 1.14
Measurement of hemagglutination-inhibiting antibody to influenza virus in the 1976 influenza vaccine program: methods and test reproducibility. J Infect Dis (1977) 1.13
The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med (1988) 1.12
Evaluation of a solid-phase immunoassay with fluorescein isothiocyanate-conjugated heterogeneous or monoclonal antibodies for identification of virus isolates, with influenza virus as a model. J Clin Microbiol (1982) 1.11
Effect of test system on the ability of monoclonal antibodies to detect antigenic drift in influenza A(H1N1) virus haemagglutinins. J Gen Virol (1981) 1.10
Cold-adapted variants of influenza virus A. I. Comparison of the genetic properties of ts mutants and five cold-adapted variants of influenza virus A. Virology (1977) 1.10
Detection of monoclonal influenza antibodies synthesized in culture by hybridoma cells with a solid-phase indirect immunofluorometric assay. J Virol Methods (1980) 1.09
Do family physicians make good sentinels for influenza? Arch Fam Med (1993) 1.06
Antiviral activity of intranasally applied human leukocyte interferon. Antimicrob Agents Chemother (1978) 1.06
Detection of adenovirus by enzyme-linked immunosorbent assay. J Clin Microbiol (1979) 1.03
Role of the M2 protein in influenza virus membrane fusion: effects of amantadine and monensin on fusion kinetics. Virology (1993) 1.03
Human nasal epithelial cell culture system: evaluation of response to human interferons. Infect Immun (1977) 1.02
Recovery of applied human leukocyte interferon from the nasal mucosa of chimpanzees and humans. J Clin Microbiol (1976) 1.01
The preparation and properties of 14 C-carboxamidomethylated subunits from A 2 -1957 influenza neuraminidase. Biochim Biophys Acta (1972) 1.01
Comparative studies of wild-type and 'cold-mutant' (temperature sensitive) influenza viruses: geneology of the matrix (M) and non-structural (NS) proteins in recombinant cold-adapted H3N2 viruses. J Gen Virol (1977) 1.00
Morbidity and mortality associated with influenza B in the United States, 1979-1980. A report from the Center for Disease Control. J Infect Dis (1980) 0.99
Flocculation of influenza virus by specific anti-neuraminidase antibody. Arch Gesamte Virusforsch (1970) 0.99
Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus. J Infect Dis (1982) 0.98
Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. Infect Immun (1980) 0.98
Antigenic drift in influenza A/USSR/90/77(H1N1) variants selected in vitro with monoclonal antibodies. Virology (1981) 0.98
Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. Virology (1992) 0.98
Characterization of influenza virus neuraminidases: peptide changes associated with antigenic divergence between early and late N2 neuraminidases. J Virol (1973) 0.98
Evaluation of the single radial hemolysis test for measuring hemagglutinin- and neuraminidase-specific antibodies to H3N2 influenza strains and antibodies to influenza B. J Clin Microbiol (1977) 0.98
Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose. J Infect Dis (1984) 0.97
Hybrid formation of influenza virus at 25 . Proc Soc Exp Biol Med (1972) 0.97
Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadine. J Gen Virol (1993) 0.97
An outbreak of influenza B in an elderly population. J Infect Dis (1981) 0.96
Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination. Dev Biol Stand (1978) 0.96
Comparison of the immune response to variant influenza type B hemagglutinins expressed in vaccinia virus. Virology (1987) 0.95